1) Thymosinα1(Tα1)
胸腺肽α1(Tα1)
2) recombinant human Thymosin α1(rh-Tα1)
重组人胸腺肽α1(rh-Tα1)
3) thymosin alpha 1 (Tα_1)
胸腺素α1(Tα1)
4) thymosinα1
胸腺肽α1
1.
Efficiency of thymosinα1 combined with Kushensu on treating chronic hepatitis B with iamivudine resistance.;
胸腺肽α1联合苦参素胶囊治疗拉米夫定耐药的慢性乙型肝炎疗效观察
2.
AIM:To prepare and evaluate the in vitro release characteristics of thymosinα1 tablet(Tα1 tablet).
目的:制备胸腺肽α1结肠释放片(Tα1片),评价其体外释药性能。
3.
The absorption of thymosinα1 in rat colon and enhancement effect of different absorption enhancers or protease inhibitor (sodium desoxycholate, Carbomer 940, water-soluble chitosan and bacitracin) were investigated using in situ perfusion method.
考察了大鼠在体结肠对胸腺肽α1(1)及其在各吸收促进剂或酶抑制剂(去氧胆酸钠、卡波姆940、水溶性壳聚糖和杆菌肽)作用下的吸收情况。
5) thymosin α1
胸腺肽α1
1.
Effect of thymosin α1 on immune function and cytokines in patients with abdominal sepsis;
胸腺肽α1对严重外科感染病人免疫功能和细胞因子的影响
2.
Effect of thymosin α1 for advanced non-small-cell lung cancer in chemotherapy patients;
胸腺肽α1在非小细胞肺癌治疗中的应用
3.
Prevention of Ventilator-associated Pneumonia in the Patient with Longer Mechanical Ventilation Using Thymosin α1 (Zadaxin);
胸腺肽α1在长期机械通气患者预防呼吸机相关肺炎的应用
6) thymosin alpha 1
胸腺肽α1
1.
OBJECTIVE To investigate the effects of thymosin alpha 1 on monocyte human leukocyte antigen DR(HLA-DR) and other immune parameters and the clinical significance in patients with acute cerebral infarction(ACI) and severe hospital acquired pneumonia(SHAP).
目的:探讨胸腺肽α1治疗对脑梗死并发重症医院获得性肺炎(SHAP)患者单核细胞人类白细胞抗原DR(HLA-DR)等免疫指标的影响及其临床意义。
2.
Objective To produce monoclonal antibody (McAb) against thymosin alpha 1 and make a foundation for the research and identification of thymosin alpha 1.
目的 研制胸腺肽α1(Tα1)单克隆抗体 ,为Tα1作用机制的阐明奠定基础。
补充资料：胸腺肽
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：乙型肝炎、各类慢性肝炎和重病肝炎、疱疹、尖锐湿疣、病毒性角膜炎等。
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：乙型肝炎、各类慢性肝炎和重病肝炎、疱疹、尖锐湿疣、病毒性角膜炎等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条